Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis
NCT02014623
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
51
Enrollment
OTHER_GOV
Sponsor class
Conditions
Allergic Rhinitis
Interventions
OTHER:
Grass pollen sublingual immunotherapy tablet
DRUG:
Control
Sponsor
Bayside Health